• Fund Type: Closed-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

H&Q Healthcare Investors

+ Add to Watchlist

HQH:US

26.0500 USD 0.8500 3.37%

As of 20:04:06 ET on 04/16/2014.

Snapshot for H&Q Healthcare Investors (HQH)

Open: 25.3600 High - Low: 26.0820 - 25.1600 Primary Exchange: New York
Volume: 126,832 52-Week Range: 19.7500 - 31.9600 Beta vs BTK: 0.7572

ETF Chart for HQH

No chart data available.
  • HQH:US 26.0500
  • 1D
  • 1M
  • 1Y
25.2000
Interactive HQH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for HQH

H&Q Healthcare Investors is a diversified, closed-end management investment company incorporated in the USA. The Trust's objective seeks long-term capital appreciation. The Trust will invest 80% of its assets in health services and medical technology companies, that have significant potential for above-average growth.

Inception Date: 1987-04-22 Telephone: 1-617-772-8500
Managers: DANIEL R OMSTEAD
Web Site: www.teklacap.com

Fundamentals for HQH

NAV (on 2014-04-16) 25.9800
Assets (M) (on 2014-04-16) 734.7133
Shares out (M) 28.28
Market Cap (M) 736.69
% Premium 0.27
Average 52-Week % Premium -0.3156
Fund Leveraged N

Dividends for HQH

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-02-27) 0.5300
Dividend Yield (ttm) 7.26%

Performance for HQH

1-Month -12.23% 1-Year +30.49%
3-Month -8.59% 3-Year +29.57%
Year To Date -1.75% 5-Year +28.76%
Expense Ratio 1.26

Top Fund Holdings for HQH

Filing Date: 12/31/2013
Name Position Value % of Total
Gilead Sciences Inc 1,039,942 78,151,641 10.619%
Celgene Corp 353,091 59,658,255 8.106%
Regeneron Pharmaceuticals Inc 178,740 49,196,398 6.685%
Biogen Idec Inc 132,195 36,981,551 5.025%
Alexion Pharmaceuticals Inc 259,405 34,516,429 4.690%
Amgen Inc 286,769 32,737,549 4.448%
Actavis plc 158,892 26,693,856 3.627%
Vertex Pharmaceuticals Inc 346,735 25,762,411 3.501%
Perrigo Co PLC 154,896 23,770,340 3.230%
iShares Nasdaq Biotechnology E 97,826 22,212,372 3.018%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil